Amanta Healthcar

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE084K01015
  • NSEID: AMANTA
  • BSEID: 544502
INR
109.19
3.84 (3.64%)
BSENSE

Apr 02

BSE+NSE Vol: 2.51 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.51 lacs (92.76%) Volume

Shareholding (Dec 2025)

FII

1.10%

Held by 6 FIIs

DII

7.20%

Held by 5 DIIs

Promoter

63.56%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 405 Cr ()

stock-summary
P/E

25.00

stock-summary
Industry P/E

31

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

1.94

Revenue and Profits:
Net Sales:
74 Cr
(Quarterly Results - Dec 2025)
Net Profit:
5 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.83%
0%
-0.83%
6 Months
-19.86%
0%
-19.86%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Amanta Healthcar for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary

Open Market Purchase Of Equity Shares By Promoter

01-Apr-2026 | Source : BSE

We would like to inform you that we have received Disclosure in Form C pursuant to Regulation 7(2) of SEBI (PIT) Regulations 2015 from the Promoter

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011

28-Mar-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bandhan Mutual Fund

Insider Trading/SAST Regulation

28-Mar-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(1) of SEBI SAST Regulations 2011 for Bandhan Mutual Fund.

Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-2.00%
EBIT Growth (5y)
9.30%
EBIT to Interest (avg)
1.30
Debt to EBITDA (avg)
3.27
Net Debt to Equity (avg)
1.99
Sales to Capital Employed (avg)
0.80
Tax Ratio
28.62%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.34%
ROCE (avg)
13.97%
ROE (avg)
8.18%
Valuation key factors
Factor
Value
P/E Ratio
25
Industry P/E
31
Price to Book Value
2.01
EV to EBIT
12.30
EV to EBITDA
8.50
EV to Capital Employed
1.73
EV to Sales
1.85
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.03%
ROE (Latest)
4.98%
Technicals key factors
Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Bullish
KST
Dow Theory
Mildly Bullish
Bearish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (3.99%)

FIIs

Held by 6 FIIs (1.1%)

Promoter with highest holding

Bhavesh Girishbhai Patel (16.1%)

Highest Public shareholder

Bandhan Small Cap Fund (3.99%)

Individual Investors Holdings

16.91%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 5.08% vs 8.54% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 282.64% vs -65.53% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "74.49",
          "val2": "70.89",
          "chgp": "5.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.36",
          "val2": "14.65",
          "chgp": "4.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.06",
          "val2": "5.15",
          "chgp": "-1.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-2.63",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.63",
          "val2": "1.21",
          "chgp": "282.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.62%",
          "val2": "20.67%",
          "chgp": "-0.05%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Amanta Healthcar"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Amanta Healthcar"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "274.71",
          "val2": "280.34",
          "chgp": "-2.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "59.67",
          "val2": "57.49",
          "chgp": "3.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "27.95",
          "val2": "33.64",
          "chgp": "-16.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "10.50",
          "val2": "3.63",
          "chgp": "189.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.72%",
          "val2": "20.51%",
          "chgp": "1.21%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary
Dec'25
Sep'25
Change(%)
Net Sales
74.49
70.89
5.08%
Operating Profit (PBDIT) excl Other Income
15.36
14.65
4.85%
Interest
5.06
5.15
-1.75%
Exceptional Items
0.00
-2.63
100.00%
Standalone Net Profit
4.63
1.21
282.64%
Operating Profit Margin (Excl OI)
20.62%
20.67%
-0.05%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 5.08% vs 8.54% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 282.64% vs -65.53% in Sep 2025

Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
274.71
280.34
-2.01%
Operating Profit (PBDIT) excl Other Income
59.67
57.49
3.79%
Interest
27.95
33.64
-16.91%
Exceptional Items
0.00
0.00
Standalone Net Profit
10.50
3.63
189.26%
Operating Profit Margin (Excl OI)
21.72%
20.51%
1.21%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details